The T-cell response to HIV

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 11, 2012, Pages

  Walker, Bruce ^a   McMichael, Andrew ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GAG PROTEIN; GAMMA INTERFERON; HLA B ANTIGEN; HLA B57 ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR STRESS RESPONSE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; HIV RAPID TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOGENETICS; MONONUCLEOSIS; OPPORTUNISTIC INFECTION; POPULATION GENETICS; T LYMPHOCYTE; VIRUS LOAD; VIRUS PATHOGENESIS; ADAPTIVE IMMUNITY; GENETICS; IMMUNE EVASION; IMMUNOLOGY; PHYSIOLOGY; REVIEW; VIROLOGY;

AIDS VIRUS;

ADAPTIVE IMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; IMMUNE EVASION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84877143138     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007054     Document Type: Article

References (145)

1. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D, Johnston MN, Corcoran C, Wurcel AG, Fitzpatrick CA, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77: 2081-2092.
2. Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, Le Gall S, John M, Mothe BR, Lee PK, Kalife ET, et al. 2004. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 78: 7069-7078.
3. Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, Eldridge RL, Addo MM, Poon SH, Phillips MN, Robbins GK, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 193: 169-180.
4. + T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest 109: 837-843.
5. Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M, Yu XG, Draenert R, Johnston MN, Strick D, et al. 2003a. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17: 2581-2591.
6. Altfeld M, Addo MM, Shankarappa R, Lee PK, Allen TM, Yu XG, Rathod A, Harlow J, O'Sullivan K, Johnston MN, et al. 2003b. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 77: 7330-7340.
7. + T cell response against HIV-1. PLoS Med 3: e403.
8. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
9. + T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med 198: 903-911.
10. Bansal A, Gough E, Sabbaj S, Ritter D, Yusim K, Sfakianos G, Aldrovandi G, Kaslow RA, Wilson CM, et al. 2005. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS 19: 241-250.
11. Bansal A, Carlson J, Yan J, Akinsiku OT, Schaefer M, Sabbaj S, Bet A, Levy DN, Heath S, Tang J, et al. 2010. CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription. J Exp Med 207: 51-55.
12. Barber DL, Wherry EJ, Ahmed R. 2003. Cutting edge: Rapid in vivo killing by memory CD8 T cells. J Immunol 171: 27-31.
13. Berger CT, Carlson JM, Brumme CJ, Hartman KL, Brumme ZL, Henry LM, RosatoPC, Piechocka-Trocha A, Brockman MA, Harrigan PR, et al. 2010. Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J Exp Med 207: 61-75.
14. + T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 75: 11983-11991.
15. + T cells. Blood 107: 4781-4789.
16. Betts MR, Harari A. 2008. Phenotype and function of protective T cell immune responses in HIV. Curr Opin HIV AIDS 3: 349-355.
17. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68: 6103-6110.
18. Brockman MA, Brumme ZL, Brumme CJ, Miura T, Sela J, Rosato PC, Kadie CM, Carlson JM, Markle TJ, Streeck H, et al. 2010. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated in chronic infection. J Virol 84: 11937-11949.
19. Brumme ZL, Brumme CJ, Carlson J, Streeck H, John M, Eichbaum Q, Block BL, Baker B, Kadie C, Markowitz M, et al. 2008. Marked epitope-and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 82: 9216-9227.
20. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, SwensonLC, Tao I, Szeto S, Rosato P, et al. 2009. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. PLoS One 4: e6687.
21. + T cell function. J Virol 85: 733-741.
22. Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, Seoighe C, Treurnicht F, de Rosa DA, Hide W, Karim SA, et al. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog 4: e1000033.
23. Crawford H, Lumm W, Leslie A, Schaefer M, Boeras D, Prado JG, Tang J, FarmerP, Ndung'u T, Lakhi S, et al. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J Exp Med 206: 909-921.
24. Dahirel V, Shekhar K, Pereyra F, Miura T, Artyomov M, Talsania S, Allen TM, Altfeld M, Carrington M, Irvine DJ, et al. 2011. Coordinate linkage of HIV evolution reveals regions of immunologic vulnerability. Proc Natl Acad Sci 108: 11530-11535.
25. + T-cell effector activity in HIV primary infection. J Clin Invest 104: 1431-1439.
26. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
27. Deeks SG, Walker BD. 2007. Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27: 406-416.
28. + T cells. Nature 417: 95-98.
29. Douek DC, Roederer M, Koup RA. 2009. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 60: 471-484.
30. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, Brander C, Holmes EC, Chang SC, Feeney ME, Addo MM, et al. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 199: 905-915.
31. Draenert R, Allen TM, Liu Y, Wrin T, Chappey C, Verrill CL, Sirera G, Eldridge RL, Lahaie MP, Ruiz L, et al. 2006. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. J Exp Med 203: 529-539.
32. + T cell help distinguishes HIV-2 from HIV-1 infection. J Immunol 176: 6973-6981.
33. Duvall MG, Precopio ML, Ambrozak DA, Jaye A, McMichael AJ, Whittle HC, Roederer M, Rowland-Jones SL, Koup RA. 2008. Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur J Immunol 38: 350-363.
34. + T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 76: 2298-2305.
35. Fellay J, Frahm N, Shianna KV, Cirulli ET, Casimiro DR, Robertson MN, HaynesBF, Geraghty DE, McElrath MJ, Goldstein DB, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
36. Ferrari G, Korber B, Goonetilleke N, Liu MK, Turnbull EL, Salazar-Gonzalez JF, Hawkins N, Self S, Watson S, Betts MR, et al. 2011. Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog 7: e1001273.
37. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, et al. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS 17: 1871-1879.
38. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, Han CS, Gleasner CD, Green L, Lo CC, et al. 2010. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5: e12303.
39. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, et al. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344: 1668-1675.
40. Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, Derdeyn CA, Tang J, Kaslow RA, Bansal A, et al. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205: 1009-1017.
41. Goh WC, Markee J, Akridge RE, Meldorf M, Musey L, Karchmer T, Krone M, Collier A, Corey L, Emerman M, et al. 1999. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J Infect Dis 179: 548-557.
42. +T-cell epitopes. J Virol 80: 4717-4728.
43. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, et al. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206: 1253-1272.
44. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, RosenbergES, Nguyen T, Allen R, Trocha A, et al. 2001. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412: 334-338.
45. Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Martin JE, McCluskey MM, Chakrabarti BK, Lamoreaux L, et al. 2006. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J Infect Dis 194: 1650-1660.
46. Gray CM, Mlotshwa M, Riou C, Mathebula T, de Assis Rosa D, Mashishi T, Seoighe C, Ngandu N, van Loggerenberg F, Morris L, Mlisana K, et al. 2009. Human immunodeficiency virus-specific γ interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point. J Virol. 83: 470-478.
47. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, Drummond DD, Legasse AW, Axthelm MK, Oswald K, Trubey CM, et al. 2009. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15: 293-299.
48. Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne-Johnson L, Whizin N, Oswald K, Shoemaker R, Swanson T, et al. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-527.
49. Harari A, Bart PA, Stohr W, Tapia G, Garcia M, Medjitna-Rais E, Burnet S, Cellerai C, Erlwein O, Barber T, et al. 2008. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 205: 63-77.
50. + T-cells is a correlate of HIV elite control. PLoS Pathog 6: e1000917.
51. Ho DD, Sarngadharan MG, Resnick L, Dimarzoveronese F, Rota TR, Hirsch MS. 1985. Primary human T-lymphotropic virus type III infection. Ann Intern Med 103: 880-883.
52. Huang S, Dunkley-Thompson J, Tang Y, Macklin EA, Steel-Duncan J, Singh-Minott I, Ryland EG, Smikle M, Walker BD, Christie CD, et al. 2008. Deficiency of HIV-Gag-specific T cells in early childhood correlates with poor viral containment. J Immunol 181: 8103-8111.
53. International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
54. + T lymphocytes. Nature 421: 852-856.
55. + T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189: 991-998.
56. Julg B, Moodley ES, Qi Y, Ramduth D, Reddy S, Mncube Z, Gao X, Goulder PJ, Detels R, Ndung'u T, et al. 2011. Possession of HLA Class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection. J Infect Dis 203: 803-809.
57. Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, Shea AK, Trocha AK, Walker BD. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol 73: 6715-6720.
58. + T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. J Exp Med 204: 1803-1812.
59. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 2: 405-411.
60. Kaufmann DE, Bailey PM, Sidney J, Wagner B, Norris PJ, Johnston MN, CosimiLA, Addo MM, Lichterfeld M, Altfeld M, et al. 2004. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol 78: 4463-4477.
61. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, Fujiwara M, Hachiya A, Koizumi H, et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
62. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
63. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13: 46-53.
64. + Lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog 6: e1000747.
65. Koibuchi T, Allen TM, Lichterfeld M, Mui SK, O'Sullivan KM, Trocha A, KalamsSA, Johnson RP, Walker BD. 2005. Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection. J Virol 79: 8171-8181.
66. Kosmrlj A, Read EL, Qi Y, Allen TM, Altfeld M, Deeks SG, Pereyra F, CarringtonM, Walker BD, Chakraborty AK. 2010. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 465: 350-354.
67. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68: 4650-4655.
68. Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, Martin MP, Hunt P, Deeks SG, Telenti A, et al. 2011. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472: 495-498.
69. Lacap PA, Huntington JD, Luo M, Nagelkerke NJ, Bielawny T, Kimani J, WachihiC, Ngugi EN, Plummer FA. 2008. Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort. AIDS 22: 1029-1038.
70. + memory T cells. J Exp Med 186: 859-865.
71. Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. 1985. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 313: 79-84.
72. Lazaro E, Godfrey SB, Stamegna P, Ogbechie T, Kerrigan C, Zhang M, WalkerBD, Le Gall S. 2009. Differential HIV epitope processing in monocytes and CD4 T cells affects cytotoxic T lymphocyte recognition. J Infect Dis 200: 236-243.
73. Le Gall S, Buseyne F, Trocha A, Walker BD, Heard JM, Schwartz O. 2000. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J Virol 74: 9256-9266.
74. Le Gall S, Stamegna P, Walker BD. 2007. Portable flanking sequences modulate CTL epitope processing. J Clin Invest 117: 3563-3575.
75. Lichterfeld M, Yu XG, Cohen D, Addo MM, Malenfant J, Perkins B, Pae E, Johnston MN, Strick D, Allen TM, et al. 2004. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 18: 1383-1392.
76. + T cells after early HIV-1 infection. J Virol 81: 4199-4214.
77. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, Margolick JB, Phair JP, Mellors JW. 2000. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 181: 872-880.
78. Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T, Persaud N, Trigona W, Fu TM, Sinclair E, et al. 2001. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 255: 27-40.
79. + T lymphocytes against an immunodominant cryptic epitope select for viral escape. J Exp Med 204: 2505-2512.
80. Maness NJ, Sacha JB, Piaskowski SM, Weisgrau KL, Rakasz EG, May GE, BuechlerMB, Walsh AD, Wilson NA, Watkins DI. 2009. Novel translation products from the SIVmac239 Env-encoding mRNA contain both Rev and cryptic T cell epitopes. J Virol 83: 10280-10285.
81. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, ThobakgaleC, Honeyborne I, Crawford H, Matthews P, et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 80: 3617-3623.
82. + T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
83. Matthews PC, Prendergast A, Leslie A, Crawford H, Payne R, Rousseau C, Rolland M, Honeyborne I, Carlson J, Kadie C, et al. 2008. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 82: 8548-8559.
84. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. 2010. The immune response during acute HIV-1 infection: Clues for vaccine development. Nat Rev Immunol 10: 11-23.
85. Mellors JW, Rinaldo CR Jr., Gupta P, White RM, Todd JA, Kingsley LA. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170.
86. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, MartinoL, Hallahan CW, Selig SM, Schwartz D, Sullivan J, et al. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci 97: 2709-2714.
87. Miura T, Brockman MA, Brumme ZL, Brumme CJ, Pereyra F, Trocha A, Block BL, Schneidewind A, Allen TM, Heckerman D, et al. 2009a. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J Virol 83: 140-149.
88. Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, BlockBL, Brumme ZL, Brumme CJ, Baker B, et al. 2009b. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 83: 2743-2755.
89. Miura T, Brumme ZL, Brockman MA, Rosato P, Sela J, Brumme CJ, Pereyra F, Kaufmann DE, Trocha A, Block BL, Daar ES, et al. 2010. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol 84: 7581-7591.
90. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439-1443.
91. Murray HW, Rubin BY, Masur H, Roberts RB. 1984. Impaired production of lymphokines and immune (γ) interferon in the acquired immunodeficiency syndrome. N Engl J Med 310: 883-889.
92. Ngumbela KC, Day CL, Mncube Z, Nair K, Ramduth D, Thobakgale C, MoodleyE, Reddy S, de Pierres C, Mkhwanazi N, et al. 2008. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses 24: 72-82.
93. Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336: 484-487.
94. Papagno L, Appay V, Sutton J, Rostron T, Gillespie GM, Ogg GS, King A, Makadzanhge AT, Waters A, Balotta C. et al. 2002. Comparison between HIV-and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol 130: 509-517.
95. Peixoto A, Evaristo C, Munitic I, Monteiro M, Charbit A, Rocha B, Veiga-Fernandes H. 2007. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. J Exp Med 204: 1193-1205.
96. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, Baker B, Trocha A, Rosenberg R, Mackey E, Ueda P, Lu Z, et al. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis 197: 563-571.
97. + T cell survival in HIV infection. J Exp Med 203: 2281-2292.
98. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, Elvin JG, Rothbard JA, Bangham CR, Rizza CR. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459.
99. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5: 518-525.
100. Plata F, Cerottini JC, et al. 1975. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system. Eur J Immunol 5: 227-233.
101. Plata F, Autran B, Martins LP, Wain-Hobson S, Raphaël M, Mayaud C, Denis M, Guillon JM, Debré P. 1987. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328: 348-351.
102. + T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med 16: 1147-1151.
103. Quinn TC, Wawer MJ, et al. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342: 921-929.
104. + T-cell epitopes in acute clade C virus Infection. J Infect Dis 204: 768-776.
105. + cell responses. J Infect Dis 192: 1588-1596.
106. Richardson JS. 2000. Early ribbon drawings of proteins. Nat Struct Biol 7: 624-625.
107. Ritchie AJ, Campion SL, Kopycinski J, Moodie Z, Wang ZM, Pandya K, Moore S, Liu MK, Brackenridge S, Kuldanek K, et al. 2011. Differences in HIV-specific T cell responses between HIV-exposed and-unexposed HIV-seronegative individuals. J Virol 85: 3507-3516.
108. + T cell responses associated with control of viremia. Science 278: 1447-1450.
109. Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
110. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Gallimore A, Corrah T. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1: 59-64.
111. Rychert J, Saindon S, Placek S, Daskalakis D, Rosenberg E. 2007. Sequence variation occurs in CD4 epitopes during early HIV infection. J Acquir Immune Defic Syndr 46: 261-267.
112. Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, DeckerJM, Wang S, Baalwa J, Kraus MH, et al. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206: 1273-1289.
113. Schenal M, Lo Caputo S, Fasano F, Vichi F, Saresella M, Pierotti P, Villa ML, Mazzotta F, Trabattoni D, Clerici M. 2005. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS 19: 653-661.
114. + lymphocytes. Science 283: 857-860.
115. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, Rinaldo CR, Craggs SL, Allgaier RL, Power KA, et al. 2007. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol 81: 12382-12393.
116. Schneidewind A, Brockman MA, Sidney J, Wang YE, Chen H, Suscovich TJ, Li B, Adam PI, Allgaier RL, Mothé BR, et al. 2008. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J Virol 82: 5594-5605.
117. Schneidewind A, Brumme ZL, Brumme CJ, Power KA, Reyor LL, O'Sullivan K, Gladden A, Hempel U, Kuntzen T, Wang YE, et al. 2009. Transmission and long-term stability of compensated CD8 escape mutations. J Virol. 83: 3993-3997.
118. Shaw GM, Hunter E. 2011. HIV transmission. Cold Spring Harb Perspect Med doi: 10. 1101/cshperspect. a006965.
119. Shedlock DJ, Shen H. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
120. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83: 3719-3733.
121. Staprans SI, Barry AP, Silvestri G, Safrit JT, Kozyr N, Sumpter B, Nguyen H, McClure H, Montefiori D, Cohen JI, et al. 2004. Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. Proc Natl Acad Sci 101: 13026-13031.
122. + T cells. PLoS Med 5: e100.
123. + T cells. J Virol 83: 7641-7648.
124. Sun JC, Bevan MJ. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
125. Sun Y, Schmitz JE, Buzby AP, Barker BR, Rao SS, Xu L, Yang ZY, Mascola JR, Nabel GJ, Letvin NL. 2006. Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge. J Virol 80: 10950-10956.
126. + T lymphocyte responses in rhesus monkeys. Virology 406: 48-55.
127. Tenzer S, Wee E, Burgevin A, Stewart-Jones G, Friis L, Lamberth K, Chang CH, Harndahl M, Weimershaus M, Gerstoft J, et al. 2009. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol 10: 636-646.
128. + T cells leads to reversible immune dysfunction. Nat Med 12: 1198-1202.
129. Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, Tebit DM, ZhaoH, Avila S, Lobritz MA, et al. 2009. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog 5: e1000365.
130. Turnbull EL, Wong M, Wang S, Wei X, Jones NA, Conrod KE, Aldam D, Turner J, Pellegrino P, Keele BF, et al. 2009. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J Immunol 182: 7131-7145.
131. + T cells to antigen stimulation in vivo. Nat Immunol 1: 47-53.
132. Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. 2009. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457: 196-199.
133. Vigneault F, Woods M, Buzon MJ, Li C, Pereyra F, Crosby SD, Rychert J, ChurchG, Martinez-Picado J, Rosenberg ES, et al. 2011. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol 85: 3015-3019.
134. Wahren B, Morfeldt-Månsson L, Biberfeld G, Moberg L, Sönnerborg A, Ljungman P, Werner A, Kurth R, Gallo R, Bolognesi D. 1987. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol 61: 2017-2023.
135. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234: 1563-1566.
136. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, et al. 1987. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328: 345-348.
137. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, et al. 2005. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191: 1403-1409.
138. + memory T cells. Nature 441: 890-893.
139. Williams LD, Bansal A, Sabbaj S, Heath SL, Song W, Tang J, Zajac AJ, GoepfertPA. 2011. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J Virol 85: 2316-2324.
140. Wright JK, Novitsky V, Brockman MA, Brumme ZL, Brumme CJ, Carlson JM, Heckerman D, Wang B, Losina E, Leshwedi M, et al. 2011. Influence of gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. J Virol 85: 3996-4006.
141. Yang PL, Althage A, Chung J, Maier H, Wieland S, Isogawa M, Chisari FV. 2010. Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci 107: 798-802.
142. + T-cell responses following acute HIV-1 infection. J Virol 76: 8690-8701.
143. + T cells from genetically identical twins infected with the same HIV-1 strain. J Virol 81: 12666-12669.
144. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G. 2005. HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci 102: 7239-7244.
145. Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, SanchezH, Frahm N, Linde CH, Hewitt HS, et al. 2006. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 80: 3122-3125.